Sub-Saharan women using modern contraceptives more likely to be HIV tested

Sub-Saharan ladies using contemporary contraceptives most likely to be HIV checked

Females in sub-Saharan Africa who use modern contraceptives are most likely to be tested for HIV than those who do not, according to a research released April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues. HIV/AIDS stays a major public health challenge for ladies in sub-Saharan Africa, and medical consultations for use of modern-day contraceptives could provide a chance to provide confidential HIV testing. The authors of the present research analysed information from the Market and Health survey for Congo, Mozambique, Nigeria, and Uganda to examine the relationship in between usage of modern-day contraceptives and HIV screening in ladies. They discovered that in the overall pooled sample and particularly in Mozambique, ladies who used modern contraceptives, consisting of oral contraceptives and prophylactics, were most likely to go through HIV screening than females who depend on traditional contraceptive methods, such as regular abstaining or withdrawal. However, a low percentage of the total population in Mozambique was discovered to use modern contraceptives. This favorable association was not seen in the other nations studied but was seen in the pooled total …
See all stories on this subject

Lynparzatm (olaparib) now offered to NHS clients in England and Wales with BRCA-mutated ovarian cancer

AstraZeneca has announced that LynparzaTM (olaparib) is now available for NHS clients in England and Wales with platinum-sensitive fallen back (PSR) BRCA-mutated (BRCAm) state-of-the-art serous ovarian cancer who have had 3 or more courses of platinum-based chemotherapy.1 The National Institute for Health and Care Quality (NICE) provided Technology Appraisal Assistance (TAG) on 27 January 2016 recommending olaparib as a cost-efficient post- chemotherapy maintenance treatment alternative for this patient group. It is now over 90 days since the TAG was released, and Scientific Commissioning Groups, NHS England and regional authorities are required to ensure that olaparib is moneyed and accessible to clients. Professor Jonathan Ledermann, Professor of Medical Oncology at the University College London Cancer Institute and Main Detective of the pivotal olaparib medical “We have gone into a new age for how females with ovarian cancer and a BRCA mutation are treated by the NHS in England and Wales. Previously, treatment alternatives have been limited to conventional chemotherapy and surgery. It is necessary that clinical personnel offer their patients with ovarian cancer a test for a BRCA mutation as quickly as …
See all stories on this topic

Fireflies light the way to female HIV transmission: Glowing virus maps points of entry through entire female reproductive system for very first time

Finding the vulnerable points where HIV gets in the female reproductive system is like searching for needles in a haystack. But Northwestern Medicine scientists have resolved that challenge by developing a glowing map of the first cells to be contaminated with a HIV-like virus. Through an animal model, the scientists revealed for the first time that HIV goes into cells throughout the whole female reproductive tract from the labia to the ovary, not just the cervix, as previously thought. “It’s a technical accomplishment that supplies instant insights into the earliest transmission events,” stated lead investigator Thomas Hope, teacher of cell and molecular biology at Northwestern University Feinberg School of Medication. “Now we know which locations are susceptible to HIV and can investigate why does the virus enter here and not everywhere else?” The HIV transmission research was recently published in Cell Host & Microorganism. “If we are going to stop women from getting infected, we need to stop the very first cells from getting contaminated,” Hope stated. “A week after the initial infection, there are hundreds of thousands of contaminated cells, and it’s extremely challenging to stop. If you can stop it earlier, then you …
See all stories on this topic

What Disorders Can Affect the Placenta Throughout Pregnancy?The placenta and its health are crucial to the health of a lady’s pregnancy and fetal advancement. This organ supplies oxygen, nutrients, and filters fetal waste throughout pregnancy. It likewise plays a vital role in hormone production and protects the fetus from bacteria and infections. The blood-rich placenta is signed up with to the uterine wall and connects to the baby by method of the umbilical cord. Most often the placenta connects itself to the top or side of the uterine wall. At times, however, it may grow or connect to the uterus in a manner that can cause health problems. Many elements influence the health of the placenta, consisting of: There are lots of complications that can affect the placenta. The most typical conditions are discussed below. Placenta previa is a condition in which the placenta attaches to the wall of the uterus very low down. In doing so, the placenta partly or completely covers the cervix. This condition occurs in 0.5-1 % of pregnancies. The condition may deal with as the pregnancy progresses, nevertheless. Placenta previa is most common in women who are: There are two kinds of placenta previa: limited and complete. Marginal placenta previa is when the placenta only partly cov … See all stories on this topic

No Comments

Post a Comment